- NCR Corp (NYSE:NCR) is amid exclusive talks for sale to private-equity firm Veritas Capital, the Wall Street Journal reports. NCR has a market value of $4 billion.
- Lately, Kohl’s Corp (NYSE:KSS) and Walgreens Boots Alliance, Inc (NASDAQ:WBA) ended strategic reviews without striking deals citing challenges in the financing market.
- Also Read: Here’s Why Zendesk Shares Are Trading Higher Today
- NCR clocked 21% revenue growth to $1.86 billion in Q1, missing its guidance of $1.9 billion – $1.95 billion. NCR downsized its full-year guidance to $8 billion in revenue, citing Q1 shortfall and expected net residual impact across the remainder of the year.
- In February, NCR, formerly known as the National Cash Register Co. and once part of AT&T Inc (NYSE:T), launched a strategic review process.
- Price Action: NCR shares traded higher by 9.45% at $31.85 in the premarket on the last check Tuesday.
SCHOTT Pharma And KORU Medical Systems Announce Collaboration To Advance Large Volume Subcutaneous Infusion
The companies, KORU Medical, manufacturer of the proprietary, large-volume, Freedom Infusion System (the "Freedom System") and SCHOTT Pharma, manufacturer of SCHOTT TOPPAC® prefillable polymer syringes (PFS), intend
